First case report of inflammatory myofibroblastic tumor of peritoneal cavity in a living donor liver transplantation recipient

Naganathan Selvakumar , Parul Saboti , Sumaid Kaul , Subash Gupta

Hepatoma Research ›› 2017, Vol. 3 : 86 -9.

PDF
Hepatoma Research ›› 2017, Vol. 3:86 -9. DOI: 10.20517/2394-5079.2017.01
Case Report
Case Report

First case report of inflammatory myofibroblastic tumor of peritoneal cavity in a living donor liver transplantation recipient

Author information +
History +
PDF

Abstract

Post-transplantation malignancies are well known complications after liver transplantation. Certain malignancies are more common in pediatric recipients than adults. Inflammatory myofibroblastic tumors (IMTs) are reactive neoplasms with miniscule malignant potential. IMTs are more common after hematopoietic stem cell transplantation. However, there is 1 case reported in the literature after deceased donor liver transplantation. The authors describe a case of IMT after living donor liver transplantation. The patient was a 1-year-old girl who underwent living donor liver transplantation (LDLT) for decompensated cirrhosis secondary to extra hepatic biliary atresia. Six months post LDLT routine ultrasonography revealed multiple solid abdominal masses. Repeated biopsies were inconclusive. Hence surgical excision was carried out. Histopathological examination revealed IMT. Immunohistochemistry was positive for anaplastic-lymphoma kinase activity. Ceritinib, a tyrosine kinase inhibitor, was used as adjuvant chemotherapy for 1 year. At 1.5 years (at the time of writing this paper) of follow-up, the child was disease free on imaging (whole body positron emission tomography-computed tomography). This will be the first case of IMT after LDLT to be reported in the literature.

Keywords

Inflammatory myofibroblastic tumor / living donor liver transplantation / extrahepatic biliary atresia

Cite this article

Download citation ▾
Naganathan Selvakumar, Parul Saboti, Sumaid Kaul, Subash Gupta. First case report of inflammatory myofibroblastic tumor of peritoneal cavity in a living donor liver transplantation recipient. Hepatoma Research, 2017, 3: 86-9 DOI:10.20517/2394-5079.2017.01

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Pillai AA.Management of de novo malignancies after liver transplantation..Transplant Rev (Orlando).2015;29:38-41

[2]

Piselli P,Fratino L,Ettorre GM,Serraino D.De novo malignancies after organ transplantation: focus on viral infections..Curr Mol Med2013;13:1217-27

[3]

Lykavieris P,Waguet J.Inflammatory pseudotumor after liver transplantation..J Pediatr Gastroenterol Nutr2000;31:309-12

[4]

Bronzino P,Bagnasco F,Dezzani C,Iannucci P,Sacchi M.Intra-abdominal inflammatory myofibroblastic pseudotumor: case report and review of the literature..G Chir2005;26:362-4

[5]

Tufan A.Inflammatory pseudotumors after stem cell transplantation..Hematol Rep2015;7:5848 PMCID:PMC4591496

[6]

Lykavieris P,Waguet J.Inflammatory pseudotumor after liver transplantation..J Pediatr Gastroenterol Nutr2000;31:309-12

[7]

Vroobel K,Dainton M,Fisher C.ALK-positive inflammatory myofibroblastic tumor harboring ALK gene rearrangement, occurring after allogeneic stem cell transplant in an adult male..Pathol Res Pract2016;212:743-6

[8]

Chaudhary P.Mesenteric inflammatory myofibroblastic tumors..Ann Gastroenterol2015;28:49-54

PDF

70

Accesses

0

Citation

Detail

Sections
Recommended

/